GleamWall
中文EN

CSTL CASTLE BIOSCIENCES INC

Services-Medical Laboratories · Nasdaq · SEC CIK 1447362 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY9.8%
TTM net income YoY-88.1%
TTM EPS YoY-72.7%
Revenue 3-yr CAGR25.2%
Net income 3-yr CAGR—

Margins

Gross margin77.1%
Operating margin-7.4%
Net margin-6.1%
FCF margin1.1%
EBITDA margin-4.4%

Returns

ROE-4.9%
ROA-4.0%
ROIC (approx.)-5.5%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets17.4%
Debt / equity0.02x
Current ratio5.28x
Interest coverage-51.16x

Cash quality & payout

Operating cash flow / net income-1.73x
Accruals ratio-11.0%
Payout ratio—
Capex / revenue9.5%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$102.89M$103.55M$83.68M$87.01M$83.04M$86.19M$87.99M$86.31M
Cost of revenue$23.92M$23.70M$20.53M$18.32M$18.70M$17.63M$16.38M$16.18M
Gross profit$78.97M$79.85M$63.15M$68.69M$64.34M$68.56M$71.61M$70.13M
R&D expense$15.81M$14.54M$14.43M$13.52M$12.96M$12.79M$12.59M$11.77M
SG&A expense$63.79M$66.12M$64.90M$56.73M$55.91M$58.06M$58.62M$49.97M
Operating income-$2.73M-$3.07M-$18.41M-$3.83M-$6.80M-$4.25M-$27.93M$4.05M
Interest expense$197,000$193,000$134,000$24,000$24,000$21,000$17,000$156,000
Income tax$298,000$370,000$109,000-$382,000$115,000-$4.67M-$423,000-$1.71M
Net income-$4.10M-$2.06M-$14.52M-$2.33M-$501,000$4.52M-$25.85M$9.59M
EBITDA-$656,000-$1.25M-$14.48M-$50,000-$5.26M-$2.80M$1.84M$9.82M
EPS (basic)-0.13-0.07-0.49—-0.020.16-0.90—
EPS (diluted)-0.13-0.07-0.49—-0.020.15-0.90—
Weighted avg. shares (diluted)30.63M30.40M29.89M—29.07M29.55M28.61M—
Balance sheet
Cash & equivalents$77.99M$62.12M$63.76M$116.73M$85.56M$82.23M$89.69M$119.71M
Short-term investments$199.67M$204.69M$197.92M$182.78M$201.99M$193.70M$185.46M$173.42M
Receivables$52.10M$48.34M$42.26M$43.38M$49.48M$52.31M$56.35M$51.22M
Inventory$10.38M$10.58M$10.46M$10.25M$8.65M$8.37M$6.85M$8.13M
Current assets$356.86M$341.10M$328.90M$361.10M$357.57M$348.67M$349.39M$360.15M
PP&E, net$111.46M$104.68M$100.93M$97.44M$84.89M$74.06M$55.42M$51.12M
Goodwill$10.70M$10.70M$10.70M$10.70M$10.70M$10.70M$10.70M$10.70M
Intangibles$80.80M$84.40M$86.66M$88.88M$91.16M$93.43M$67.21M$95.54M
Total assets$579.41M$561.18M$547.80M$578.56M$562.79M$544.73M$501.71M$531.24M
Current liabilities$67.61M$56.51M$48.76M$68.68M$55.31M$50.89M$37.27M$49.39M
Short-term debt$4.17M$2.92M$1.67M$417,000$0$1.94M$1.11M$278,000
Long-term debt$5.92M$7.16M$8.40M$9.64M$10.05M$8.10M$8.92M$9.74M
Total debt$10.08M$10.07M$10.07M$10.06M$10.05M$10.04M$10.03M$10.02M
Total liabilities$100.96M$91.15M$86.39M$107.68M$95.74M$89.35M$61.41M$75.40M
Shareholders' equity$478.44M$470.03M$461.42M$470.87M$467.05M$455.38M$440.31M$455.83M
Net debt-$67.91M-$52.04M-$53.70M-$106.67M-$75.51M-$72.19M-$79.66M-$109.69M
Shares outstanding30.77M30.51M30.30M29.69M29.16M28.98M28.84M28.48M
Cash flow statement
Operating cash flow$19.74M$15.20M-$22.13M$26.93M$22.63M$20.82M-$6.04M$24.36M
Capital expenditure$7.49M$8.65M$12.46M$7.18M$14.83M$9.26M$4.74M$7.57M
Free cash flow$12.25M$6.55M-$34.58M$19.75M$7.80M$11.56M-$10.78M$16.80M
Investing cash flow-$4.73M-$15.96M-$25.80M$8.83M-$18.39M-$28.38M-$22.43M$5.77M
Financing cash flow$866,000-$886,000-$5.03M-$4.59M-$919,000$101,000-$1.55M-$5.38M
Depreciation & amortization$2.08M$1.82M$3.93M$3.78M$1.54M$1.45M$29.76M$5.77M
Stock-based compensation$11.23M$11.59M$9.78M$11.41M$12.10M$11.21M$11.18M$11.44M

Free plan shows the latest 8 periods; Pro shows all 35 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.